首页> 外文期刊>Annals of Surgery >Mortality of intra-abdominal desmoid tumors in patients with familial adenomatous polyposis: A single center review of 154 patients
【24h】

Mortality of intra-abdominal desmoid tumors in patients with familial adenomatous polyposis: A single center review of 154 patients

机译:家族性腺瘤性息肉病患者腹腔内类胶质瘤的死亡率:154名患者的单中心回顾

获取原文
获取原文并翻译 | 示例
       

摘要

INTRODUCTION: Intra-abdominal desmoid tumors are one of the leading causes of death in patients with familial adenomatous polyposis. Their behavior is unpredictable and their biology is poorly understood, accounting for the lack of a standardized medical and surgical approach. The aim of this study was to evaluate the mortality rate of patients with intra-abdominal desmoid tumors and to identify prognostic factors for the evolution of the disease. MATERIALS AND METHODS: A total of 154 patients with intra-abdominal desmoid tumors were included in the study. Each tumor was staged and each patient was categorized according to the stage of their most advanced tumor. Mortality was analyzed and the univariate risk factors associated with survival were included in a multivariable Cox regression model. A scoring system was derived from the multivariate analysis to refine outcomes within stages. RESULTS: Five-year survival of patients with stage I, II, III, and IV intra-abdominal desmoid tumor were 95%, 100%, 89%, and 76% respectively (P < 0.001). Severe painarcotic dependency, tumor size larger than 10 cm, and need for total parenteral nutrition were shown to further define survival within stages. Five-year survival rate of stage IV patient with all of the above-mentioned risk factors was only 53%. CONCLUSIONS: Our study confirmed the validity of the staging system to predict mortality in patients with intra-abdominal desmoid tumors and identified additional risk factors able to better define the risk of death within each stage. Risk stratification is crucial in directing patients with advanced disease and poor prognosis to the most appropriate medical and surgical options.
机译:简介:腹腔内类胶质瘤是家族性腺瘤性息肉病患者死亡的主要原因之一。他们的行为无法预测,并且对其生物学了解甚少,这说明缺乏标准化的医学和外科手术方法。这项研究的目的是评估腹腔内类胶质瘤患者的死亡率,并确定疾病发展的预后因素。材料与方法:本研究共纳入154例腹腔内类胶质瘤患者。对每个肿瘤进行分期,并根据其最晚期肿瘤的分期对每个患者进行分类。分析了死亡率,并将与生存相关的单因素风险因素包括在多变量Cox回归模型中。从多元分析中得出一个评分系统,以细化阶段内的结果。结果:I,II,III和IV期腹腔内类胶质瘤患者的五年生存率分别为95%,100%,89%和76%(P <0.001)。严重的疼痛/麻醉依赖性,肿瘤大小大于10厘米以及需要全胃肠外营养被证明可以进一步确定分期的生存率。具有上述所有危险因素的IV期患者的五年生存率仅为53%。结论:我们的研究证实了分期系统在预测腹腔内类胶质瘤患者死亡率方面的有效性,并确定了能够更好地定义每个阶段死亡风险的其他危险因素。风险分层对于将晚期疾病和预后不良的患者引导至最合适的医疗和手术选择至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号